Home » Topics » Regulatory

Regulatory
RSS

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...